Brandes A, Bethge K P, Gonska B D, Diederich K W
Klinik für Kardiologie Medizinische Universität zu Lübeck.
Z Kardiol. 1996 Apr;85(4):237-47.
This prospective cross-sectional study include 100 consecutive patients (56 males, 44 females, 29 to 86 (mean = 67.5 +/- 12.2) years) with ventricular inhibited demand pacemakers 0.1 to 94.7 (mean 23.3 +/- 25.4) months after pacemaker implantation. Fifty-two patients were free of symptoms, whereas 48 patients were still complaining of syncope, dizziness, or palpitations. After history, physical examination, and 12-lead standard ECG all patients underwent 24-h Holter monitoring. A computer-aided analysis of spontaneous arrhythmias was done first. In a second run computed-aided analysis of transient pacemaker dysfunctions was performed with a specially designed pacemaker module. There were no significant differences between asymptomatic and symptomatic patients with regard to the incidence of transient pacemaker dysfunctions, with regard to defined types of pacemaker dysfunctions, spontaneous ventricular arrhythmias, and with regard to supraventricular tachycardias. A significant difference between asymptomatic and symptomatic patients was found, however, regarding the Lown classification of ventricular arrhythmias, because asymptomatic patients showed class 0 and I/II arrhythmias more frequently (p < 0.025). In the 100 patients a total of 6609 pacemaker dysfunctions were observed, 5104 failures to sense and 1505 inappropriate inhibitions. Most patients showed up to 240 pacemaker dysfunctions per 24 h. There were no failures to capture. Different types of pacemaker dysfunctions were found with different clinical implications. Due to the Holter findings in nine patients pacemakers were reprogrammed or replaced. After pacemaker implantation the number of patients with severe symptoms significantly decreased compared to the number of patients before pacemaker implantation. Nonetheless, there was a number of patients still complaining of symptoms after pacemaker implantation. In only a few patients did pacemaker implantation worsen symptoms . Our data show that with use of long-term ECG transient pacemaker dysfunctions and spontaneous arrhythmias are more frequent than patients' history and common standard techniques in the pacemaker clinic may suggest Holter monitoring, therefore, is a useful diagnostic tool, not only in symptomatic, but also in asymptomatic pacemaker patients. It allows to obtain a reliable survey of the real amount of transient pacemaker dysfunctions in the individual patient, which is the base for further therapeutic decisions.
这项前瞻性横断面研究纳入了100例连续的患者(56例男性,44例女性,年龄29至86岁(平均67.5±12.2岁)),这些患者在植入心室按需起搏器后0.1至94.7个月(平均23.3±25.4个月)。52例患者无症状,而48例患者仍主诉晕厥、头晕或心悸。在进行病史采集、体格检查和12导联标准心电图检查后,所有患者均接受了24小时动态心电图监测。首先对自发性心律失常进行计算机辅助分析。在第二轮中,使用专门设计的起搏器模块对短暂性起搏器功能障碍进行计算机辅助分析。在短暂性起搏器功能障碍的发生率、特定类型的起搏器功能障碍、自发性室性心律失常以及室上性心动过速方面,无症状患者和有症状患者之间没有显著差异。然而,在室性心律失常的Lown分级方面,无症状患者和有症状患者之间存在显著差异,因为无症状患者更频繁地出现0级和I/II级心律失常(p<0.025)。在这100例患者中,共观察到6609次起搏器功能障碍,其中5104次感知失败和1505次不适当抑制。大多数患者每24小时出现多达240次起搏器功能障碍。没有捕捉失败的情况。发现不同类型的起搏器功能障碍具有不同的临床意义。根据动态心电图检查结果,对9例患者的起搏器进行了重新编程或更换。与植入起搏器前的患者数量相比,植入起搏器后有严重症状的患者数量显著减少。尽管如此,仍有一些患者在植入起搏器后仍主诉有症状。只有少数患者植入起搏器后症状加重。我们的数据表明,使用长期心电图检查发现,短暂性起搏器功能障碍和自发性心律失常比起搏器诊所的患者病史和常规标准技术所提示的更为频繁。因此,动态心电图监测是一种有用的诊断工具,不仅适用于有症状的起搏器患者,也适用于无症状的起搏器患者。它能够可靠地了解个体患者短暂性起搏器功能障碍的实际数量,这是进一步治疗决策的基础。